Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Classical phenylketonuria is a severe form of phenylketonuria (PKU) an inborn error of amino acid metabolism characterized in untreated patients by severe intellectual deficit and neuropsychiatric complications.
Biomarker and diagnostic research for classic phenylketonuria has been reported in the published literature.
15 clinical trials registered, 7 recruiting. Interventions under study include drug therapy, other interventions, gene therapy, and biologic therapy. Pipeline includes 3 PHASE4, 3 PHASE3, 3 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07241234](https://clinicaltrials.gov/study/NCT07241234) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about classic phenylketonuria
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria |
PHASE1 |
Agios Pharmaceuticals, Inc. |
RECRUITING |
[NCT06289348](https://clinicaltrials.gov/study/NCT06289348) | Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience. | — | Assistance Publique - Hôpitaux de Paris | RECRUITING |
[NCT06971731](https://clinicaltrials.gov/study/NCT06971731) | A Study of JNT-517 in Participants With Phenylketonuria (PKU) | PHASE3 | Otsuka Pharmaceutical Development & Commercialization, Inc. | RECRUITING |
[NCT07477691](https://clinicaltrials.gov/study/NCT07477691) | Immune Modulation During Palynziq® Treatment in Adults (IMPALA) | PHASE4 | BioMarin Pharmaceutical | RECRUITING |
[NCT01659749](https://clinicaltrials.gov/study/NCT01659749) | Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria | NA | Emory University | RECRUITING |
25 publications have been identified in PubMed for classic phenylketonuria. Research spans Epidemiology / Natural History (56%), Basic Science / Preclinical (16%), and Diagnostic / Biomarker (12%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 14 | 56% |
Laboratory research | 4 | 16% |
Testing and diagnosis research | 3 | 12% |
Research summaries | 2 | 8% |
Other research | 1 | 4% |
New treatment approaches | 1 | 4% |
Tan MY (2026). [PMID: 42135233](https://pubmed.ncbi.nlm.nih.gov/42135233/). *Zhonghua Er Ke Za Zhi*. [Epidemiology / Natural History]
Garcia-Arenas D (2026). [PMID: 42070971](https://pubmed.ncbi.nlm.nih.gov/42070971/). *J Inherit Metab Dis*. [Epidemiology / Natural History]
Giret C (2026). [PMID: 41421263](https://pubmed.ncbi.nlm.nih.gov/41421263/). *Molecular genetics and metabolism*. [Basic Science / Preclinical]
Dóczi TI (2026). [PMID: 41625943](https://pubmed.ncbi.nlm.nih.gov/41625943/). *Sage open pediatrics*. [Review / Meta-Analysis]
Lah M (2026). [PMID: 42250073](https://pubmed.ncbi.nlm.nih.gov/42250073/). *Adv Ther*. [Other]
Liu S (2025). [PMID: 40763961](https://pubmed.ncbi.nlm.nih.gov/40763961/). *Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics*. [Epidemiology / Natural History]
Kuzucu FN (2025). [PMID: 40293582](https://pubmed.ncbi.nlm.nih.gov/40293582/). *Metabolic brain disease*. [Epidemiology / Natural History]
Consentino MC (2025). [PMID: 39940237](https://pubmed.ncbi.nlm.nih.gov/39940237/). *Nutrients*. [Basic Science / Preclinical]
Dos Santos Y (2025). [PMID: 40135139](https://pubmed.ncbi.nlm.nih.gov/40135139/). *JIMD reports*. [Epidemiology / Natural History]
Yuskiv N (2025). [PMID: 40901071](https://pubmed.ncbi.nlm.nih.gov/40901071/). *JIMD reports*. [Epidemiology / Natural History]